Medico Remedies has announced a board meeting on 8th May 2025, where the audited financial results for the quarter and year ended 31st March 2025 were approved.

Subsequently, the company addressed a formatting issue raised by the regulator regarding the headers in the cash flow statement, clarifying that an incorrect header was inadvertently used and has since been corrected in the revised filings.

No financial figures or performance highlights were disclosed in the correspondence.

The company’s management has ensured compliance and accuracy in the resubmitted documents.